Journal SAM (January 2013): An Evidence-Based Review of Quantitative SPECT Imaging and Potential Clinical Applications

MOC Part II SAM Modules

An Evidence-Based Review of Quantitative SPECT Imaging and Potential Clinical Applications

Member Fee:  Free
Non-Member Fee:  $90.00

Release Date:  1/01/2013
Expiration Date: 1/31/2016

Continuing Education Credit Information

The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment.   2.5 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.


On successful completion of this activity, participants should be able to: 

  1. Review the current status of SPECT imaging, with an emphasis on clinical applications for quantitative interpretations.
  2. Consider the requirements for quantitative SPECT imaging and instrumentation, software, and image calibration.
  3. Acquire knowledge of the capabilities of quantitative SPECT with a view to developing new clinical applications.

Target Audience

The LLSAP is designed for all nuclear medicine specialists and other physicians, pharmacists and technologists who practice diagnostic and/or therapeutic nuclear medicine.

Faculty Disclosure(s)



Dale L. Bailey1,2 and Kathy P. Willowson3
1.Department of Nuclear Medicine, Royal North Shore Hospital, St. Leonards, Australia; 2.Discipline of Medical Radiation Sciences, University of Sydney, Sydney, Australia; and 3.School of Physics, University of Sydney, Sydney, Australia

Dr. Bailey is an employee of NSW Health, University of Sydney, and an investigator for NHMRC, ARC, Cure Cancer Australia. Dr. Willowson is supported by the Australian Research Council and the NSW Cancer Council in conjunction with the Cure Cancer Australia Foundation. In accordance with ACCME Revised Standards for Commercial Support and SNM Conflict-of-Interest Policy, the authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.